Abbott’s panbio rapid antigen test received CE Mark for asymptomatic screening and sample collection
On Jan. 26, 2021, Abbott announced it had received CE Mark for two new uses of its Panbioル COVID-19 Ag Rapid Test Device for the detection of the SARS-CoV-2 virus: asymptomatic testing and self-swabbing.
Panbio COVID-19 Ag’s label wasn updated with clinical data on asymptomatic individuals, which enabled mass testing of people who do not currently present symptoms of the disease. According to a study published in JAMA,2 at least 50% of COVID-19 infections are estimated to have originated from exposure to asymptomatic individuals.
Tags:
Source: Abbott
Credit: